Entanglemental News
Entanglemental News

Anduril funding talks test a possible $100 billion defense-tech valuation

The defense-technology company is evaluating capital options that could lift its valuation from $61 billion to about $100 billion, but it says no terms, structure, price or timing have been decided.

NEWS AUDIO

Listen to this article

Ready to listen

Anduril is evaluating a new financing that could value the defense-technology company at about $100 billion, roughly $39 billion above the $61 billion valuation reached in May. The size of the raise and its terms have not been finalized.

One structure under discussion would divide the financing into two stages. Investors could commit to a later tranche at a higher valuation, with both closings potentially occurring within a year and the second price linked to financial performance.

The comparison is unusually rapid. Anduril raised $5 billion in May at $61 billion, after a June 2025 round valued it at $30.5 billion. A $100 billion outcome would more than triple the 2025 benchmark and increase the May valuation by about 64%.

The company’s operating growth provides part of the argument. Anduril said 2025 revenue more than doubled to $2.2 billion, while contracts span the U.S. Defense Department, military services and allied governments in Europe.

Sector capital has also accelerated. Defense-technology startups attracted more than $12 billion in the first half of 2026, above the nearly $10 billion raised during all of 2025, as demand expands for drones, autonomous systems and AI-enabled warfare.

Investors are financing a shift toward cheaper, expendable systems and domestic production capacity. Anduril has expanded products and solid-rocket-motor manufacturing, but capital committed ahead of demand still requires contracts, production discipline and delivery at scale.

Anduril said no decisions have been made and characterized assertions about terms, structure, pricing or timing as speculative. The $100 billion figure should therefore be treated as a possible negotiation benchmark, not a completed round or current formal valuation.

The next concrete signal will be a disclosed financing agreement. Investors will need to test whether revenue growth, contract backlog and manufacturing milestones justify a higher second-stage price, while the company must avoid a structure that turns future performance targets into refinancing pressure.